DUBLIN--(BUSINESS WIRE)-- Research and
Markets(http://www.researchandmarkets.com/research/db2156/brazil_in_vitro_di)
has announced the addition of GlobalData's new report
"Brazil
In Vitro Diagnostics Market Outlook to 2017 - Clinical
Chemistry Genetic Testing, Haematology, Histology and
Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture" to their offering.

GlobalData's new report provides key market data on the
Brazil In Vitro Diagnostics market. The report provides value
(USD million) data for each segment and sub-segment within
seven market categories - Clinical Chemistry, Genetic
Testing, Haematology, Histology And Cytology, Immuno
Chemistry, Infectious Immunology and Microbiology Culture.
The report also provides company shares and distribution
shares data for each of the aforementioned market categories.

Scope

Market size and company share data for In Vitro
Diagnostics market categories - Clinical Chemistry, Genetic
Testing, Haematology, Histology And Cytology, Immuno
Chemistry, Infectious Immunology and Microbiology Culture.

Annualized market revenues (USD million) data for each of
the segments and sub-segments within seven market categories.
Data from 2003 to 2010, forecast forward for 7 years to 2017.

2010 company shares and distribution shares data for each
of the seven market categories.

Global corporate-level profiles of key companies
operating within the Brazil In Vitro Diagnostics market.

Reasons to buy

Develop business strategies by identifying the key market
categories and segments poised for strong growth.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying
who-stands-where in the Brazil In Vitro Diagnostics
competitive landscape.

Develop capital investment strategies by identifying the
key market segments expected to register strong growth in the
near future.

Companies Mentioned:

F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Abbott Laboratories

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

HORIBA, Ltd.

Becton, Dickinson and Company

Sysmex Corporation

Ortho-Clinical Diagnostics Inc.

DiaSorin S.p.A

Beckman Coulter, Inc.

Alere Inc.

Phadia AB

Qiagen N.V.

Thermo Fisher Scientific Inc.

Gen-Probe Incorporated

PerkinElmer, Inc.

For more information visit
http://www.researchandmarkets.com/research/db2156/brazil_in_vitro_di

Read the rest here:
Research and Markets: Brazil In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing ...